Navigation Links
Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes

) of patients continuing past 24 weeks in this study achieved the ADA target A1C goal of less than seven percent on JANUVIA 50 mg/metformin 1000 mg twice daily (n=153) compared to 44 percent on metformin 1000 mg twice daily alone (n=134). Further, 48 percent of patients treated with JANUVIA 50 mg/metformin 500 mg twice daily (n=147), 25 percent of patients treated with metformin 500 mg twice daily (n=117), and 23 percent of patients treated with JANUVIA 100 mg once daily (n=106) reached the ADA target A1C goal.

Duration of response was demonstrated by data showing that 85 percent of patients treated with JANUVIA 50 mg/metformin 1000 mg twice daily and 70 percent of patients treated with JANUVIA 100 mg once daily who achieved the target A1C goal of less than seven percent at Week 24 had a Week 54 A1C value of less than seven percent (n=96 and 33, respectively). In addition, 80 percent of patients treated with JANUVIA 50 mg/metformin 500 mg twice daily (n=65), 79 percent of patients treated with metformin 1000 mg twice daily (n=63), and 59 percent of patients treated with metformin 500 mg twice daily (n=34) who reached a goal A1C of less than seven percent at Week 24 had a Week 54 A1C value of less than seven percent.

Over the 54 week study, five out of 182 patients (three percent) treated with JANUVIA 50 mg/metformin 1000 mg twice daily and two out of 182 patients (one percent) treated with metformin 1000 mg twice daily had at least one episode of hypoglycemia. Incidences of gastrointestinal adverse experiences were similar to those observed with metformin alone (26 percent vs. 31 percent with metformin 1000 mg twice daily).

"Initial therapy with one agent is often unsuccessful at getting patients to blood sugar goals. Many patients may require initial combination therapy, and this study provides important and useful information about the use of sitagliptin and metformin, in addition to diet and exercise, in order to achieve and maintain blood su
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
2. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
3. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
4. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
5. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
6. Everest Data on Short- and Long-Term Use of Otsukas Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACCs Late Breaking Clinical Trials
7. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
8. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
9. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
10. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
Post Your Comments:
(Date:2/26/2015)... 2015  MEI Pharma, Inc. (Nasdaq: MEIP ), ... therapies for cancer, announced today that Daniel P. Gold ... the Cowen and Company 35 th Annual Health Care ... time from the Boston Marriott Copley Place. A live webcast ... A replay will be available approximately one hour after the ...
(Date:2/26/2015)... , February 26, 2015 ABIVAX, a ... human vaccines, today announced that it has dosed in ... Phase IIb/III clinical trial of ABX203 which is taking place ... region. The study is designed to assess whether ABX203 can ... B (CHB) via controlling viral load for a much longer ...
(Date:2/26/2015)... Feb. 26, 2015 ANSYS (NASDAQ: ... manufacturer of diesel engines and global power leader, Cummins ... broad access to the ANSYS ® portfolio. This ... solve some of the industry,s most challenging multiphysics problems ... innovative products on the market. The multi-year ...
Breaking Medicine Technology:MEI Pharma to Present at Cowen and Company Health Care Conference 2MEI Pharma to Present at Cowen and Company Health Care Conference 3ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 2ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 3ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 4ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 5Cummins Standardizes On ANSYS Engineering Simulation Software 2Cummins Standardizes On ANSYS Engineering Simulation Software 3
(Date:2/26/2015)... As the great passage beyond midlife ... meaning, more substantial roles and connections that span the ... live a life that still matters? As The Aspen ... Next Year Total Immersion Retreat , answers to these ... results and jump-starts a healthier life. A new round ...
(Date:2/26/2015)... Imagine a day without access to clean, ... and there was no one to help. For more than ... In 2015, more than 2.5 billion people will also lack ... A new initiative led by Nevada’s Desert Research Institute ... specifically on women – who often bear the brunt of ...
(Date:2/26/2015)... The COR HEALTH division of Vets Access, ... to offer customers a full line of Topricin® pain ... and effectively address muscle, joint, and nerve pain. ... LLC, Montrose, MI, that is dedicated to providing natural, ... is a research and development leader in topical natural ...
(Date:2/26/2015)... 26, 2015 The Reproductive Science Center ... newly renovated office in Lawrenceville, NJ. , ... of New Jersey’s physicians, and NJ Top Docs, have ... in the areas of infertility and reproductive medicine. This ... success rates and providing current, high quality medical treatments ...
(Date:2/26/2015)... CA (PRWEB) February 26, 2015 Beckman ... “Diversity of extracellular vesicles and their cargo in cell-to-cell ... vesicles and their relevance for cell-to-cell communication. The webinar ... March 4, 2015 at 8:00am PT. , Every cell ... extracellular vesicles (EVs) , often called “exosomes” or “microvesicles.” ...
Breaking Medicine News(10 mins):Health News:The Aspen Club on Actively Aging: Telling a New Story on Aging 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 3Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 2Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 3Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3
... are addicted to glucose to generate their energy, but new ... rely on fatty acid metabolism to grow and to evade ... cells vulnerable to drugs that force them to commit suicide, ... Center and The University of Texas Medical School at Houston ...
... be a problem among today,s youth. While many children ... prevalent in children that are different from the social ... of bullying, research shows a high rate of sexual ... A new study conducted by doctors at Nationwide Children,s ...
... ... Center to provide financial assistance to breast cancer patients. , ... Mesa, AZ (PRWEB) January 27, 2010 -- ... Inc. to launch a vehicle and boat donation program. The Processing Center allows TBCS ...
... , , Society of Interventional Radiology Member ... A. Nemcek Jr., M.D., FSIR, in January 2011 ... Ziv J Haskal, M.D., FSIR, has been named editor of the ... Radiology (JVIR)—for a five-year term beginning in January 2011 . ...
... and Centre for Molecular Medicine and Therapeutics have uncovered ... in Huntington,s disease, and identified a possible treatment for ... published online today and will appear in the January ... Huntington,s disease is an inherited degenerative brain disease that ...
... ... why your company should win. , ... Valencia, CA (Vocus) Jan. 27, 2010 -- U.S. HealthWorks Medical Group, a leading nationwide ... businesses who want to offer an added employee benefit by getting workers vaccinated against H1N1., ...
Cached Medicine News:Health News:Researchers find leukemia cells metabolize fat to avoid cell death 2Health News:Researchers find leukemia cells metabolize fat to avoid cell death 3Health News:Study examines sexual orientation and bullying among adolescents 2Health News: The Breast Cancer Society Launches Vehicle Donation Program 2Health News: The Breast Cancer Society Launches Vehicle Donation Program 3Health News:New Editor Named for Prestigious Journal of Vascular and Interventional Radiology 2Health News:New Editor Named for Prestigious Journal of Vascular and Interventional Radiology 3Health News:New Editor Named for Prestigious Journal of Vascular and Interventional Radiology 4Health News:New Editor Named for Prestigious Journal of Vascular and Interventional Radiology 5Health News:Discovery of mechanism in brain cell injury in Huntington's offers new treatment approaches 2Health News:Twitter Contest: Free, Onsite H1N1 Vaccination Day for Winning Businesses 2
Slick® Disposable Endotracheal Stylet, Nylon-coated wire, Malleable core, Sureloc Stop helps maintain desired length for patient safety. Handle forming capability for better grip. Sterile. Single...
... spine manipulation. Prevent dental and soft tissue ... alternative to X-ray. Light-guided intubation is based ... in the neck. This technique takes advantage ... relative to the esophagus. A well-defined, circumscribed ...
All endotracheal accessories are designed to ensure your technique. The Blue Line® intubation stylets feature a satin-smooth coating and are available in three sizes....
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
Medicine Products: